期刊
ADVANCED MATERIALS
卷 34, 期 23, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202201945
关键词
antimicrobial peptides; cancer treatment; membranolytic toxicity; polymeric carriers; spatial distribution control
类别
资金
- National Key Research and Development Programs of China [2018YFA0209700]
- National Natural Science Foundation of China (NSFC) [22077073]
- Frontiers Science Center for New Organic Matter, Nankai University [63181206]
- Fundamental Research Funds for the Central Universities, Nankai University [63206015]
The study presents a polymeric carrier for antimicrobial peptides that enhances their anticancer efficacy while reducing potential side effects.
Antimicrobial peptides (AMPs) hold great potential for use in tumor treatment. However, developing AMP-based antitumor therapies is challenging due to circulatory instability, hemolytic toxicity, low selectivity, and poor cell permeability of AMPs. In this study, a polymeric carrier for AMPs (denoted as PAMP(m)-co-PPBEn/PCA) is presented that effectively enhances their anticancer efficacy while minimizing their potential side effects. By integrating multiple responsive structures at the molecular level, the carrier finely controls the spatial distribution of AMPs in different biological microenvironments, thereby effectively modulating their membranolytic ability. Upon employing KLA as the model AMP, the polymeric carrier's hemolytic toxicity during blood circulation is suppressed, its cellular internalization when reaching tumor tissues facilitated, and its membranolytic toxicity toward the mitochondria upon entering cancer cells restored and further enhanced. Animal studies indicate that this approach significantly improves the antitumor efficacy of KLA and reduces its toxicity. Considering that the loading method for most AMPs is identical to that of KLA, the polymeric carrier reported in this study may provide a feasible approach for the development of AMP-based cancer treatments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据